FDA Approves New COPD Drug

An image of the Anoro Ellipta inhalerA new drug to treat chronic obstructive pulmonary disease (COPD) has been approved by the U.S. Food and Drug Administration (FDA).

READ: What Is COPD?

LIKE BlackDoctor.org on Facebook! Get Your Daily Medicine…For LIFE!
[ione_facebook_like_box url_segment=blackdoctor.org height=”260″]

GlaxoSmithKline’s Anoro Ellipta is meant to be used once a day for long-term maintenance of airflow in patients with COPD, which is a lung disease that makes breathing difficult.